The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pruritus Type Skin Diseases Medicine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Pruritus Type Skin Diseases Medicine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1759800

No of Pages : 102

Ask Your Query

Synopsis
The global Pruritus Type Skin Diseases Medicine market size was valued at USD 5247.6 million in 2022 and is forecast to a readjusted size of USD 7049.3 million by 2029 with a CAGR of 4.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Pruritus Type Skin Diseases Medicine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Distribution Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

  • Global Pruritus Type Skin Diseases Medicine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
  • Global Pruritus Type Skin Diseases Medicine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
  • Global Pruritus Type Skin Diseases Medicine market size and forecasts, by Type and by Distribution Channel, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
  • Global Pruritus Type Skin Diseases Medicine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Pruritus Type Skin Diseases Medicine
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace

This report profiles key players in the global Pruritus Type Skin Diseases Medicine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Inc. (Allergan plc), Albireo Pharma, Inc., Astellas Pharma Inc., Cipla Limited and Eli Lilly and Company, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Pruritus Type Skin Diseases Medicine market is split by Type and by Distribution Channel. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Distribution Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • External Medication
  • Oral Medication

Market segment by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Major players covered
  • AbbVie, Inc. (Allergan plc)
  • Albireo Pharma, Inc.
  • Astellas Pharma Inc.
  • Cipla Limited
  • Eli Lilly and Company
  • GSK plc
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc. (Mylan N.V.)

Market segment by region, regional analysis covers

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Pruritus Type Skin Diseases Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pruritus Type Skin Diseases Medicine, with price, sales, revenue and global market share of Pruritus Type Skin Diseases Medicine from 2018 to 2023.
Chapter 3, the Pruritus Type Skin Diseases Medicine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pruritus Type Skin Diseases Medicine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and distribution channel, with sales market share and growth rate by type, distribution channel, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pruritus Type Skin Diseases Medicine market forecast, by regions, type and distribution channel, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pruritus Type Skin Diseases Medicine.
Chapter 14 and 15, to describe Pruritus Type Skin Diseases Medicine sales channel, distributors, customers, research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Pruritus Type Skin Diseases Medicine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pruritus Type Skin Diseases Medicine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 External Medication
1.3.3 Oral Medication
1.4 Market Analysis by Distribution Channel
1.4.1 Overview: Global Pruritus Type Skin Diseases Medicine Consumption Value by Distribution Channel: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Pruritus Type Skin Diseases Medicine Market Size & Forecast
1.5.1 Global Pruritus Type Skin Diseases Medicine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pruritus Type Skin Diseases Medicine Sales Quantity (2018-2029)
1.5.3 Global Pruritus Type Skin Diseases Medicine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 AbbVie, Inc. (Allergan plc)
2.1.1 AbbVie, Inc. (Allergan plc) Details
2.1.2 AbbVie, Inc. (Allergan plc) Major Business
2.1.3 AbbVie, Inc. (Allergan plc) Pruritus Type Skin Diseases Medicine Product and Services
2.1.4 AbbVie, Inc. (Allergan plc) Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AbbVie, Inc. (Allergan plc) Recent Developments/Updates
2.2 Albireo Pharma, Inc.
2.2.1 Albireo Pharma, Inc. Details
2.2.2 Albireo Pharma, Inc. Major Business
2.2.3 Albireo Pharma, Inc. Pruritus Type Skin Diseases Medicine Product and Services
2.2.4 Albireo Pharma, Inc. Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Albireo Pharma, Inc. Recent Developments/Updates
2.3 Astellas Pharma Inc.
2.3.1 Astellas Pharma Inc. Details
2.3.2 Astellas Pharma Inc. Major Business
2.3.3 Astellas Pharma Inc. Pruritus Type Skin Diseases Medicine Product and Services
2.3.4 Astellas Pharma Inc. Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Astellas Pharma Inc. Recent Developments/Updates
2.4 Cipla Limited
2.4.1 Cipla Limited Details
2.4.2 Cipla Limited Major Business
2.4.3 Cipla Limited Pruritus Type Skin Diseases Medicine Product and Services
2.4.4 Cipla Limited Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cipla Limited Recent Developments/Updates
2.5 Eli Lilly and Company
2.5.1 Eli Lilly and Company Details
2.5.2 Eli Lilly and Company Major Business
2.5.3 Eli Lilly and Company Pruritus Type Skin Diseases Medicine Product and Services
2.5.4 Eli Lilly and Company Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Eli Lilly and Company Recent Developments/Updates
2.6 GSK plc
2.6.1 GSK plc Details
2.6.2 GSK plc Major Business
2.6.3 GSK plc Pruritus Type Skin Diseases Medicine Product and Services
2.6.4 GSK plc Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 GSK plc Recent Developments/Updates
2.7 Merck & Co., Inc.
2.7.1 Merck & Co., Inc. Details
2.7.2 Merck & Co., Inc. Major Business
2.7.3 Merck & Co., Inc. Pruritus Type Skin Diseases Medicine Product and Services
2.7.4 Merck & Co., Inc. Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck & Co., Inc. Recent Developments/Updates
2.8 Pfizer, Inc.
2.8.1 Pfizer, Inc. Details
2.8.2 Pfizer, Inc. Major Business
2.8.3 Pfizer, Inc. Pruritus Type Skin Diseases Medicine Product and Services
2.8.4 Pfizer, Inc. Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pfizer, Inc. Recent Developments/Updates
2.9 Teva Pharmaceutical Industries Ltd.
2.9.1 Teva Pharmaceutical Industries Ltd. Details
2.9.2 Teva Pharmaceutical Industries Ltd. Major Business
2.9.3 Teva Pharmaceutical Industries Ltd. Pruritus Type Skin Diseases Medicine Product and Services
2.9.4 Teva Pharmaceutical Industries Ltd. Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
2.10 Viatris Inc. (Mylan N.V.)
2.10.1 Viatris Inc. (Mylan N.V.) Details
2.10.2 Viatris Inc. (Mylan N.V.) Major Business
2.10.3 Viatris Inc. (Mylan N.V.) Pruritus Type Skin Diseases Medicine Product and Services
2.10.4 Viatris Inc. (Mylan N.V.) Pruritus Type Skin Diseases Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Viatris Inc. (Mylan N.V.) Recent Developments/Updates
3 Competitive Environment: Pruritus Type Skin Diseases Medicine by Manufacturer
3.1 Global Pruritus Type Skin Diseases Medicine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pruritus Type Skin Diseases Medicine Revenue by Manufacturer (2018-2023)
3.3 Global Pruritus Type Skin Diseases Medicine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pruritus Type Skin Diseases Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pruritus Type Skin Diseases Medicine Manufacturer Market Share in 2022
3.4.2 Top 6 Pruritus Type Skin Diseases Medicine Manufacturer Market Share in 2022
3.5 Pruritus Type Skin Diseases Medicine Market: Overall Company Footprint Analysis
3.5.1 Pruritus Type Skin Diseases Medicine Market: Region Footprint
3.5.2 Pruritus Type Skin Diseases Medicine Market: Company Product Type Footprint
3.5.3 Pruritus Type Skin Diseases Medicine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pruritus Type Skin Diseases Medicine Market Size by Region
4.1.1 Global Pruritus Type Skin Diseases Medicine Sales Quantity by Region (2018-2029)
4.1.2 Global Pruritus Type Skin Diseases Medicine Consumption Value by Region (2018-2029)
4.1.3 Global Pruritus Type Skin Diseases Medicine Average Price by Region (2018-2029)
4.2 North America Pruritus Type Skin Diseases Medicine Consumption Value (2018-2029)
4.3 Europe Pruritus Type Skin Diseases Medicine Consumption Value (2018-2029)
4.4 Asia-Pacific Pruritus Type Skin Diseases Medicine Consumption Value (2018-2029)
4.5 South America Pruritus Type Skin Diseases Medicine Consumption Value (2018-2029)
4.6 Middle East and Africa Pruritus Type Skin Diseases Medicine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2029)
5.2 Global Pruritus Type Skin Diseases Medicine Consumption Value by Type (2018-2029)
5.3 Global Pruritus Type Skin Diseases Medicine Average Price by Type (2018-2029)
6 Market Segment by Distribution Channel
6.1 Global Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2029)
6.2 Global Pruritus Type Skin Diseases Medicine Consumption Value by Distribution Channel (2018-2029)
6.3 Global Pruritus Type Skin Diseases Medicine Average Price by Distribution Channel (2018-2029)
7 North America
7.1 North America Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2029)
7.2 North America Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2029)
7.3 North America Pruritus Type Skin Diseases Medicine Market Size by Country
7.3.1 North America Pruritus Type Skin Diseases Medicine Sales Quantity by Country (2018-2029)
7.3.2 North America Pruritus Type Skin Diseases Medicine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2029)
8.2 Europe Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2029)
8.3 Europe Pruritus Type Skin Diseases Medicine Market Size by Country
8.3.1 Europe Pruritus Type Skin Diseases Medicine Sales Quantity by Country (2018-2029)
8.3.2 Europe Pruritus Type Skin Diseases Medicine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2029)
9.3 Asia-Pacific Pruritus Type Skin Diseases Medicine Market Size by Region
9.3.1 Asia-Pacific Pruritus Type Skin Diseases Medicine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pruritus Type Skin Diseases Medicine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2029)
10.2 South America Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2029)
10.3 South America Pruritus Type Skin Diseases Medicine Market Size by Country
10.3.1 South America Pruritus Type Skin Diseases Medicine Sales Quantity by Country (2018-2029)
10.3.2 South America Pruritus Type Skin Diseases Medicine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Quantity by Distribution Channel (2018-2029)
11.3 Middle East & Africa Pruritus Type Skin Diseases Medicine Market Size by Country
11.3.1 Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pruritus Type Skin Diseases Medicine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Pruritus Type Skin Diseases Medicine Market Drivers
12.2 Pruritus Type Skin Diseases Medicine Market Restraints
12.3 Pruritus Type Skin Diseases Medicine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Pruritus Type Skin Diseases Medicine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pruritus Type Skin Diseases Medicine
13.3 Pruritus Type Skin Diseases Medicine Production Process
13.4 Pruritus Type Skin Diseases Medicine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pruritus Type Skin Diseases Medicine Typical Distributors
14.3 Pruritus Type Skin Diseases Medicine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock